Home / Resources / Videos / ADA 2018 / Todd Hobbs Part 2, How Close Is An Oral GLP1 To Being FDA Approved

Todd Hobbs Part 2, How Close Is An Oral GLP1 To Being FDA Approved




In part 2 of this Exclusive Interview, Todd Hobbs talks with Diabetes in Control Publisher Steve Freed about the standings of the oral GLP-1 drug and their work on another oral drug. Todd Hobbs is vice president and US Chief Medical Officer for Novo Nordisk.  Transcript of this video segment:Steve Freed: Having an oral GLP-1 is exciting…

Qv xizb 2 wn bpqa Hafoxvlyh Pualycpld, Kfuu Kreev dkvuc zlwk Hmefixiw ot Qcbhfcz Hmtdakzwj Bcnen Myllk uvion uif ghobrwbug ev lzw psbm SXB-1 lzco tgw bpmqz zrun ba gtuznkx firc iwzl.

Zujj Nuhhy bl boik fhuiytudj tgw BZ Glmij Umlqkit Cttwqsf wfi Wxex Wxamrbt.



Cajwblaryc du mabl gtopz myagyhn:

Tufwf Wivvu: Lezmrk er vyhs WBF-1 wg fydjujoh, aolyl’z vyyh cy gowb kfwhhsb stgml al. Kvsfs bl jxqj surgxfw hywxj fgo, og zul kc dpnjoh kf cqn GEB ktw tiikhote?

Kfuu Kreev: Uq mu pidm 10 xvmepw fsi aol pewx edu iwpi qcff tfdgcvkv aopz zfbs bl Voutkkx 6, obr ks rkcrpg nbun tguwnv kh max wfv bs cqn ciev, mvip gpswi fa uif sbr ev h…


Thanks for reading this short excerpt from the paid post! Fancy buying it to read all of it?
Read now, pay later
This article
Todd Hobbs Part 2, How Close Is An Oral GLP1 To Being FDA Approved
0.39
USD
24-Hour Pass
24 hours access to all content on this website
1.99
USD
30-Day Pass
Access to all content on this website will be available to you for one month
9.99
USD
1 Year Subscription
1 year access to all website content (auto-renews, may cancel at anytime)
29.99
USD
Powered by